Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Revenue: 2009-2025

Historic Revenue for Prestige Consumer Healthcare (PBH) over the last 17 years, with Sep 2025 value amounting to $274.1 million.

  • Prestige Consumer Healthcare's Revenue fell 3.41% to $274.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 0.02%. This contributed to the annual value of $1.1 billion for FY2025, which is 1.10% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Revenue of $274.1 million as of Q3 2025, which was up 9.85% from $249.5 million recorded in Q2 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's Revenue peaked at $296.5 million during Q1 2025, and registered a low of $237.8 million during Q1 2021.
  • For the 3-year period, Prestige Consumer Healthcare's Revenue averaged around $279.3 million, with its median value being $282.7 million (2023).
  • Its Revenue has fluctuated over the past 5 years, first grew by 17.34% in 2021, then dropped by 6.59% in 2025.
  • Prestige Consumer Healthcare's Revenue (Quarterly) stood at $274.5 million in 2021, then rose by 0.38% to $275.5 million in 2022, then increased by 2.62% to $282.7 million in 2023, then climbed by 2.68% to $290.3 million in 2024, then declined by 3.41% to $274.1 million in 2025.
  • Its Revenue was $274.1 million in Q3 2025, compared to $249.5 million in Q2 2025 and $296.5 million in Q1 2025.